There are 4 main subtypes of leukemia: acute lymphoid leukemia (ALL), acute myeloid leukemia (AML), chronic lymphoid leukemia (CLL), and chronic myeloid leukemia (CML). ALL and AML progress rapidly and therefore require more aggressive treatment to improve the life expectancy of the patient, wh...
Treatment with momelotinib (Ojjaara) improved anemia, and increased rates of transfusion independence (TI) in patients with myelofibrosis; the agent also alleviated symptoms and controlled splenomegaly for those previously exposed to a JAK inhibitor, according to real-world data ...